RE
REFG.US Medical Cannabis Pay
- Market cap
- USD 183K
- P/E
- -
- P/B
- -
- ROE
- -
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2023.
Is REFG.US undervalued?
Graham numberThe Graham number of Medical Cannabis Pay cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Medical Cannabis Pay fundamental analysis
No fundamental analysis for Medical Cannabis Pay yet.
Medical Cannabis Pay stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Medical Cannabis Pay
Medical Cannabis Payment Solutions, Inc. develops and markets a payment system for medical cannabis transactions. Its solution assists in the state tracking of sales, collection of tax, and supervision of sales to consumers. The company was incorporated in 2013 and is based in Cheyenne, Wyoming. On August 12, 2024, Medical Cannabis Payment Solutions, Inc. filed a voluntary petition for liquidation under Chapter 7 in the U.S. Bankruptcy Court for the Western District of Penns…
Full company profileMedical Cannabis Pay financial statements
2023 annualized: Fiscal year 2023 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2023, the balance sheet is the latest quarter. Figures change when the annual report is published.
Medical Cannabis Pay annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | - | 5.00K | 0.00 | 0.00 | 0.00 | - | - | - | - | - | - |
| Gross Profit | -633.00 | 3.96K | -1.04K | 0.00 | 0.00 | - | -2.84K | -12.7K | -21.9K | -21.9K | - |
| Operating Income | -117K | -261K | -393K | -510K | -4.23M | -341K | -566K | -509K | -1.75M | -34.1K | - |
| EBITDA | -117K | -260K | -392K | -510K | -4.23M | -1.34M | -563K | -311K | -1.59M | -12.2K | - |
| Net Income | -119K | -271K | -399K | -510K | -4.25M | -1.34M | -827K | -334K | -1.61M | -34.1K | - |
| EPS | 0.00 | 0.00 | 0.00 | -0.02 | -0.02 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - |
| Balance Sheet | |||||||||||
| Total Assets | 14.8K | 288K | 170K | 70.26 | 52.70 | 25.0K | 105K | 82.1K | 62.0K | 38.2K | 32.8K |
| Total Liabilities | 103K | 148K | 162K | 174.30 | 306.93 | 276K | 923K | 918K | 2.36M | 2.37M | 2.37M |
| Shareholders' Equity | -88.6K | 140K | 8.04K | -104.03 | -254.23 | -251K | -818K | -836K | -2.29M | -2.33M | -2.33M |
| Cash & Short-term Investments | 10.1K | 284K | 167K | 70.26 | 27.70 | 18.00 | 14.00 | 10.00 | 1.88K | - | - |
| Total Debt | 100K | 138K | 138K | 140.60 | 230.35 | 138K | 804K | 783K | 858K | 858K | 858K |
| Cash Flow | |||||||||||
| Operating Cash Flow | -115K | -263K | -384K | -497K | -4.21M | -1.34M | -889K | -243K | -323K | -1.88K | -43.8K |
| Capital Expenditure | 5.40K | 3.00 | 0.00 | 0.00 | 3.00 | 0.00 | 17.0K | 55.6K | 4.00 | 0.00 | 0.00 |
| Free Cash Flow | -120K | -263K | -384K | -497K | -4.21M | -1.34M | -906K | -298K | -323K | -1.88K | -43.8K |
| Ratios | |||||||||||
| ROE | - | -193.2% | -4,960.8% | - | - | - | - | - | - | - | - |
| ROA | -799.8% | -94.1% | -235.0% | -725,380.0% | -8,064,884.3% | -5,359.0% | -791.0% | -406.7% | -2,591.9% | -89.2% | - |
| Net Profit Margin | - | -5,422.2% | - | - | - | - | - | - | - | - | - |
| Debt to Equity | - | 0.98x | 17.10x | - | - | - | - | - | - | - | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Medical Cannabis Pay dividends
Medical Cannabis Pay has not paid dividends in the last 9 fiscal years.
Last stock split: 1:1000 on Feb 15, 2012.
Who owns Medical Cannabis Pay
Ownership data of Medical Cannabis Pay is not available yet.
Medical Cannabis Pay company profile
- Company name
- Medical Cannabis Pay
- Ticker
- REFG.US
- Exchange
- USA Stocks
- Sector
- Healthcare
- Industry
- Health Care Technology
- Employees
- 1
- Fiscal year end
- December
- Address
- 5516 Fort Apache Road, Cheyenne, WY, United States, 82001
- Phone
- 702-706-7011
- Website
- paywithgo.com
About Medical Cannabis Pay
Medical Cannabis Payment Solutions, Inc. develops and markets a payment system for medical cannabis transactions. Its solution assists in the state tracking of sales, collection of tax, and supervision of sales to consumers. The company was incorporated in 2013 and is based in Cheyenne, Wyoming. On August 12, 2024, Medical Cannabis Payment Solutions, Inc. filed a voluntary petition for liquidation under Chapter 7 in the U.S. Bankruptcy Court for the Western District of Pennsylvania.
Medical Cannabis Pay management
3- Mr. Jeremy RobertsCEO & President
- Mr. Tyler YoungChief Technology Officer
- Mr. Sean HullingerCorporate Counsel and Secretary